Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) Completed Phase 3 Trials for Encephalitis, Japanese B Other

IndicationsStatusPurposePhase
CompletedOther3
clinicaltrials.gov IdentifierTitleDrugs
NCT01246479Long Term Immunity and Safety Following Vaccination With the JEV IC51 (IXIARO®, JESPECT®) in Pediatric Population In Non Endemic Countries. Uncontrolled, Ph3 FU-Study